Your browser doesn't support javascript.
loading
Estimating the Incidence and Economic Cost of Lyme Disease Cases in Canada in the 21st Century with Projected Climate Change.
Ogden, Nicholas H; Dumas, Ariane; Gachon, Philippe; Rafferty, Ellen.
Afiliação
  • Ogden NH; Public Health Risk Sciences Division, Scientific Operations and Response, National Microbiology Laboratory, Public Health Agency of Canada, St-Hyacinthe, Quebec, Canada.
  • Dumas A; Groupe de recherche en épidémiologie des zoonoses et santé publique, Université de Montréal, St-Hyacinthe, Quebec, Canada.
  • Gachon P; Centre de recherche en santé publique, Université de Montréal, Montréal, Québec, Canada.
  • Rafferty E; Public Health Risk Sciences Division, Scientific Operations and Response, National Microbiology Laboratory, Public Health Agency of Canada, St-Hyacinthe, Quebec, Canada.
Environ Health Perspect ; 132(2): 27005, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38349724
ABSTRACT

BACKGROUND:

Lyme disease (LD) is emerging in Canada owing to the range expansion of the tick vector Ixodes scapularis (I. scapularis).

OBJECTIVES:

Our objective was to estimate future LD incidence in Canada, and economic costs, for the 21st century with projected climate change.

METHODS:

Future regions of climatic suitability for I. scapularis were projected from temperature output of the North American Coordinated Regional Climate Downscaling Experiment regional climate model ensemble using greenhouse gas Representative Concentration Pathways (RCPs) 4.5 and 8.5. Once regions became climatically suitable for ticks, an algorithm derived from tick and LD case surveillance data projected subsequent increasing LD incidence. Three scenarios (optimistic, intermediate, and pessimistic) for maximum incidence at endemicity were selected based on LD surveillance, and underreporting estimates, from the United States. Health care and productivity cost estimates of LD cases were obtained from the literature.

RESULTS:

Projected annual LD cases for Canada ranged from 120,000 to >500,000 by 2050. Variation in incidence was mostly due to the maximum incidence at endemicity selected, with minor contributions from variations among climate models and RCPs. Projected annual costs were substantial, ranging from CA$0.5 billion to $2.0 billion a year by 2050. There was little difference in projected incidence and economic cost between RCPs, and from 2050 to 2100, because projected climate up to 2050 is similar for RCP4.5 and RCP8.5 (mitigation of greenhouse gas emissions captured in RCP4.5 does not impact climate before the 2050s) and by 2050 the most densely populated areas of the study region are projected to be climatically suitable for ticks.

CONCLUSIONS:

Future incidence and economic costs of LD in Canada are likely to be substantial, but uncertainties remain. Because densely populated areas of Canada are projected to become endemic under conservative climate change scenarios, mitigation of greenhouse gas emissions is unlikely to provide substantial health co-benefits for LD. https//doi.org/10.1289/EHP13759.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Lyme / Gases de Efeito Estufa Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Lyme / Gases de Efeito Estufa Idioma: En Ano de publicação: 2024 Tipo de documento: Article